| 4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty |
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks. |
247wallst.com |
2025-05-16 10:46:12 |
Czytaj oryginał (ang.) |
| The 'Goldilocks' Case For Baxter International |
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and management is optimistic toward 2025 performance. |
seekingalpha.com |
2025-05-08 14:16:09 |
Czytaj oryginał (ang.) |
| Baxter Declares Quarterly Dividend |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on July 1, 2025, to stockholders of record as of May 30, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of diagn. |
businesswire.com |
2025-05-06 20:15:00 |
Czytaj oryginał (ang.) |
| Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript |
Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Shafer - Chairman and Interim Chief Executive Officer Heather Knight - Chief Operating Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi David Roman - Goldman Sachs Travis Steed - BofA Securities Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan Larry Biegelsen - Wells Pito Chickering - Deutsche Bank Danielle Antalffy - UBS Operator Good morning, ladies and gentlemen, and welcome to Baxter International's First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is copyrighted material. |
seekingalpha.com |
2025-05-01 17:27:16 |
Czytaj oryginał (ang.) |
| BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y |
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. |
zacks.com |
2025-05-01 16:50:40 |
Czytaj oryginał (ang.) |
| Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps |
On Thursday, Baxter International Inc. BAX reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents. |
benzinga.com |
2025-05-01 15:36:49 |
Czytaj oryginał (ang.) |
| Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say |
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-05-01 14:35:58 |
Czytaj oryginał (ang.) |
| Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2025-05-01 14:35:55 |
Czytaj oryginał (ang.) |
| Baxter tops quarterly estimates on strong demand for medical devices |
Medical products maker Baxter International on Thursday beat Wall Street estimates for first-quarter revenue and profit, helped by the robust demand for its intravenous (IV) solutions and patient-monitoring systems. |
reuters.com |
2025-05-01 13:13:02 |
Czytaj oryginał (ang.) |
| Baxter Reports First-Quarter 2025 Results |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. “Our solid performance in the first quarter of 2025 reflects the ongoing impact of our transformation journey,” said Brent Shafer, chair and interim chief executive officer. “Baxter today is a more focused and agile organization, well positioned to drive enhanced value for patients, healthcare providers, customers and shareholders through our rei. |
businesswire.com |
2025-05-01 11:15:00 |
Czytaj oryginał (ang.) |
| MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK |
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues. |
zacks.com |
2025-04-30 15:55:39 |
Czytaj oryginał (ang.) |
| Baxter to Present at Bank of America Securities 2025 Health Care Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Sunday, November 9, 2025. About Baxter Every day, millions of patients, caregivers and. |
businesswire.com |
2025-04-29 20:15:00 |
Czytaj oryginał (ang.) |
| Will BAX's Q1 Earnings Improve Following Transformation Completion? |
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue. |
zacks.com |
2025-04-28 18:20:34 |
Czytaj oryginał (ang.) |
| Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery |
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat. |
businesswire.com |
2025-04-10 13:16:00 |
Czytaj oryginał (ang.) |
| Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery |
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat. |
businesswire.com |
2025-04-10 13:15:00 |
Czytaj oryginał (ang.) |
| Baxter to Host Annual Meeting of Stockholders in Virtual Format |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2025 Annual Meeting) in a virtual format on Tuesday, May 6, 2025 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2025 Annual Meeting. Online access to the 2025 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2025 Annual Meeting in person. The virtual format provides a safe, c. |
businesswire.com |
2025-03-26 11:00:00 |
Czytaj oryginał (ang.) |
| Baxter Stock Likely to Gain Following the Introduction of Voalte Linq |
At the 2025 HIMSS Global Healthcare Conference, BAX unveils its Voalte Linq device, powered by Scotty assistant, a voice-activated technology. |
zacks.com |
2025-03-06 12:15:44 |
Czytaj oryginał (ang.) |
| Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings |
LAS VEGAS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today unveiled Voalte Linq device powered by Scotty assistant, the company's first voice-activated technology, at the 2025 HIMSS Global Healthcare Conference. Voalte Linq, a lightweight, wearable badge, is powered by Scotty assistant, a voice-activated technology, to better enable efficient, streamlined communication between care teams, with the goal of freeing up more of their time and energy to focus on. |
businesswire.com |
2025-03-04 11:00:00 |
Czytaj oryginał (ang.) |
| Medical Penlight Market Report 2025-2030, with BV Medical, Aspen Surgical Products, Baxter, Streamlight, GF Health Products, Rudolf Riester, American Diagnostic, HONSUN, Prestige Medical & more |
Dublin, March 03, 2025 (GLOBE NEWSWIRE) -- The "Medical Penlight Market Size, Share & Trends Analysis Report By Type (Consumables, Equipment), By Light Output (Oncology, Cardiovascular Diseases), By Usability (Disposable, Reusable), By End-use, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering. The global medical penlight market size was estimated at USD 279.7 million in 2024 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. The market is driven significantly by the product's utility in diagnosing and assessing eye and ear conditions. According to a WHO report from August 2023, approximately 2.2 billion individuals experience distance vision impairment. Out of this group, vision impairment in at least 1 billion cases could have been prevented or remains untreated. Refractive errors and cataracts are identified as the primary causes of vision impairment and blindness worldwide. Medical professionals rely on penlights for their compact size, ease of use, and focused illumination, which are crucial in conducting detailed examinations of these sensitive areas. In ophthalmology, penlights are indispensable tools for examining the pupils, assessing pupil reactions to light, and detecting abnormalities such as irregularities in pupil size or shape, which can indicate neurological or ocular health issues. They are also crucial in assessing eye movements and conducting basic visual acuity tests, aiding in the diagnosis of conditions such as strabismus or nystagmus. The increasing prevalence of eye and ear disorders, coupled with advancements in penlight technology, is driving market growth. Manufacturers are innovating with features such as LED illumination for brighter and more efficient light output, ergonomic designs for comfortable handling during prolonged use, and enhanced durability for reliability in clinical environments. These advancements not only improve diagnostic accuracy but also streamline workflow efficiency in healthcare settings. In addition, otolaryngology (ENT), medical penlights are used for examining the ear canal, tympanic membrane, and assessing hearing conditions. They help ENT specialists to visualize abnormalities, foreign objects, and signs of infection or inflammation within the ear. Worldwide, the incidence of ENT conditions such as laryngitis, tonsillitis, sinusitis, and hearing loss is increasing. According to the World Health Organization (WHO), over 10% of the global population currently experiences varying degrees of hearing loss, a figure projected to approach nearly 2 billion by 2050. Penlights equipped with otoscopic attachments further enhance their utility by enabling magnified views and facilitating detailed inspections of the ear's internal structures. This capability is crucial for diagnosing conditions such as otitis media, ear wax buildup, and tympanic membrane perforations. Furthermore, the emphasis on preventive healthcare and early diagnosis is further boosting the demand in the medical penlights market. Routine screenings and examinations using penlights help in identifying eye and ear conditions at their early stages, enabling timely interventions and improving patient outcomes. As healthcare facilities continue to prioritize patient care and diagnostic accuracy, the role of medical penlights in supporting comprehensive eye and ear health assessments is expected to expand, driving continued market growth in the coming years. Global Medical Penlight Market Report Segmentation This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, the analyst has segmented the medical penlights market report on the basis of type, light output, usability, end use and region. |
globenewswire.com |
2025-03-03 12:28:00 |
Czytaj oryginał (ang.) |
| Kontoor Brands CEO Scott Baxter sits down with Jim Cramer |
Kontoor Brands Chair, President, and CEO Scott Baxter joins 'Mad Money' host Jim Cramer to talk acquiring Helly Hansen, international business, and more. |
youtube.com |
2025-02-20 22:21:29 |
Czytaj oryginał (ang.) |
| BAX Stock Surges Following Q4 Earnings & Sales Beat, Margins Decline |
Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract. |
zacks.com |
2025-02-20 16:35:30 |
Czytaj oryginał (ang.) |
| Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript |
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript |
seekingalpha.com |
2025-02-20 14:42:06 |
Czytaj oryginał (ang.) |
| Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook |
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents. |
benzinga.com |
2025-02-20 14:41:24 |
Czytaj oryginał (ang.) |
| Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say |
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-02-20 13:30:40 |
Czytaj oryginał (ang.) |
| Baxter forecasts 2025 profit above estimates on medical device demand; shares rise |
Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade. |
reuters.com |
2025-02-20 10:17:30 |
Czytaj oryginał (ang.) |
| Baxter to Present at TD Cowen 45th Annual Health Care Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:10 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Monday, September 1, 2025. About Baxter Every day, millions of patients, caregivers and healthc. |
businesswire.com |
2025-02-18 18:15:00 |
Czytaj oryginał (ang.) |
| Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, August 30, 2025. About Baxter Every day, millions of. |
businesswire.com |
2025-02-17 18:15:00 |
Czytaj oryginał (ang.) |
| Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Tuesday, August 26, 2025. About Baxter Every day, millions of patients, caregivers an. |
businesswire.com |
2025-02-13 18:15:00 |
Czytaj oryginał (ang.) |
| Will BAX's Q4 Earnings Reflect Its Efforts to Counter Headwinds? |
Baxter might have faced fourth-quarter hurdles from Hurricane Helene. However, it expects growth in infusion therapies, pharmaceuticals and patient support systems to have driven recovery. |
zacks.com |
2025-02-12 10:31:40 |
Czytaj oryginał (ang.) |
| Baxter Declares Quarterly Dividend |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of dia. |
businesswire.com |
2025-02-11 18:30:00 |
Czytaj oryginał (ang.) |
| Countdown to Baxter (BAX) Q4 Earnings: Wall Street Forecasts for Key Metrics |
Evaluate the expected performance of Baxter (BAX) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. |
zacks.com |
2025-02-10 12:21:14 |
Czytaj oryginał (ang.) |
| Baxter CEO José Almeida to retire after near decade-long tenure |
Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's top boss. |
reuters.com |
2025-02-03 11:26:26 |
Czytaj oryginał (ang.) |
| Baxter Announces CEO Retirement and Appointment of COO |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will retire from his executive roles with the company, effective immediately. He will serve in an advisory capacity through Oct. 31, 2025. The Baxter Board of Directors has appointed lead independent director Brent Shafer as chair and interim CEO and has initiated a search for a permanent CEO with the ass. |
businesswire.com |
2025-02-03 09:30:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for January 27th |
BASFY, BNPQY and BAX have been added to the Zacks Rank #5 (Strong Sell) List on January 27, 2024. |
zacks.com |
2025-01-27 09:06:09 |
Czytaj oryginał (ang.) |
| Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February 13, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I2823858 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter. |
businesswire.com |
2025-01-22 18:15:00 |
Czytaj oryginał (ang.) |
| Bear of the Day: Baxter (BAX) |
In the world of equities, not all stocks shine brightly in the heavens. Some inevitably find themselves in the shadows, struggling against the tides of market sentiment. |
zacks.com |
2025-01-22 10:01:27 |
Czytaj oryginał (ang.) |
| Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Joe) E. Almeida, Baxter's chair, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, July 12, 2025. About Baxter Every day, millions of. |
businesswire.com |
2024-12-18 18:15:00 |
Czytaj oryginał (ang.) |
| Baxter Stock May Gain Following Five New Injectable Product Launches |
BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business segment. |
zacks.com |
2024-12-13 13:20:21 |
Czytaj oryginał (ang.) |
| Is the Options Market Predicting a Spike in Baxter International (BAX) Stock? |
Investors need to pay close attention to Baxter International (BAX) stock based on the movements in the options market lately. |
zacks.com |
2024-12-10 11:35:26 |
Czytaj oryginał (ang.) |
| Baxter resumes dialysis solution production at its hurricane-hit facility |
Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding. |
reuters.com |
2024-12-05 16:04:26 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 29th |
BALY, BAX and CENTA have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2024. |
zacks.com |
2024-11-29 08:20:33 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for November 21st |
BATRA, BAX and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on November 21, 2024. |
zacks.com |
2024-11-21 06:56:12 |
Czytaj oryginał (ang.) |
| Baxter to Present at 7th Annual Evercore HealthCONx Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 9:10 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Tuesday, June 3, 2025. About Baxter Every day, millions of patients and caregivers rely on Baxt. |
businesswire.com |
2024-11-19 18:15:00 |
Czytaj oryginał (ang.) |
| Baxter to Present at Jefferies London Healthcare Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 11:00 a.m. Greenwich Mean Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Monday, May 19, 2025. About Baxter Every day, millions of patients and caregivers rely o. |
businesswire.com |
2024-11-13 18:15:00 |
Czytaj oryginał (ang.) |
| Baxter to Present at Stifel 2024 Healthcare Conference |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 8:35 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, May 17, 2025. About Baxter Every day, millions of patients and caregivers rely on Baxter's lea. |
businesswire.com |
2024-11-12 18:15:00 |
Czytaj oryginał (ang.) |
| Baxter Declares Quarterly Dividend |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on Jan. 2, 2025, to stockholders of record as of Nov. 29, 2024. The indicated annual dividend rate is $0.68 per share of common stock. This dividend represents the new quarterly dividend rate for Baxter in anticipation of the divestiture of its Kidney Care bu. |
businesswire.com |
2024-11-11 20:45:00 |
Czytaj oryginał (ang.) |
| Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript |
Baxter International Inc. (NYSE:BAX ) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Almeida - Chairman, President and Chief Executive Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Robert Marcus - JPMorgan Pito Chickering - Deutsche Bank Vijay Kumar - Evercore ISI Joanne Wuensch - Citi Lawrence Biegelsen - Wells Fargo David Roman - Goldman Sachs Operator Good morning, ladies and gentlemen, and welcome to Baxter International's Third Quarter 2024 Earnings Conference Call. Your lines will remain in a listen-only mode until the question-and-answer segment of today's call. |
seekingalpha.com |
2024-11-08 14:16:27 |
Czytaj oryginał (ang.) |
| BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline |
Baxter reports better-than-expected third-quarter results. However, the company's gross and operating margins contract. |
zacks.com |
2024-11-08 13:10:37 |
Czytaj oryginał (ang.) |
| Baxter (BAX) Reports Q3 Earnings: What Key Metrics Have to Say |
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
zacks.com |
2024-11-08 12:36:17 |
Czytaj oryginał (ang.) |
| Baxter International (BAX) Beats Q3 Earnings Estimates |
Baxter International (BAX) came out with quarterly earnings of $0.80 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.68 per share a year ago. |
zacks.com |
2024-11-08 11:46:15 |
Czytaj oryginał (ang.) |
| Baxter cuts annual profit forecast on hurricane impact |
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading. |
reuters.com |
2024-11-08 09:35:04 |
Czytaj oryginał (ang.) |
| Baxter Reports Third-Quarter 2024 Results |
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. “Baxter delivered positive performance in the third quarter of 2024, as the company continues to execute against its strategic transformation,” said José (Joe) E. Almeida, chair, president and chief executive officer. “The pending sale of our Kidney Care business represents another defining milestone in our ongoing transformation journey. We are. |
businesswire.com |
2024-11-08 09:15:00 |
Czytaj oryginał (ang.) |
| Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings |
BAX's third-quarter results are likely to benefit from a positive pricing impact and new product launches. However, supply-chain issues are likely to have raised expenses in the quarter. |
zacks.com |
2024-11-06 10:35:19 |
Czytaj oryginał (ang.) |
| Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS |
Evaluate the expected performance of Baxter (BAX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. |
zacks.com |
2024-11-05 12:20:30 |
Czytaj oryginał (ang.) |
| Kontoor Brands CEO Scott Baxter on Q3 earnings beat |
Scott Baxter, Kontoor Brands CEO, joins CNBC's 'The Exchange' to discuss Kontoor's third-quarter earnings beat, the growth of the company through marketing, and more. |
youtube.com |
2024-10-31 16:44:55 |
Czytaj oryginał (ang.) |
| Baxter restarts IV solutions manufacturing line |
Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related flooding. |
reuters.com |
2024-10-31 13:43:15 |
Czytaj oryginał (ang.) |